Hunter Capital RTO 1 (HCRTO1) | Spotlight

Hunter Capital RTO1 is a company shell to be listed, which will then be used to list another company via a reverse acquisition. The company seeks to acquire one or more companies and associated assets in the financial markets, primarily through mergers, IPOs, acquisitions, share purchases and major reorganizations. Hunter Capital is behind the company.

Quotes for Hunter Capital RTO 1 AB

Right Now

+/-: 0.058
%: 8,26%
Latest: 0.76
High: 1.2
Low: 0.752
Volume: 62 385
Turnover (SEK): 59 151
Market Value (MSEK): 34,5
Time (Latest trade)

Board

CEO

Jacob Eriksson

Chairperson of the Board

Oliver Aleksov

Board

Jacob Eriksson
Per Karlsson

News

2026-08-31 00:01:00 Hunter Capital RTO 1 publicerar delårsrapport april - juni 2026
2026-07-06 11:10:00 Hunter Capital RTO 1 AB (publ) provides an update on the planned transaction with ResoTher Pharma A/S
2026-07-06 11:10:00 Hunter Capital RTO 1 AB (publ) lämnar uppdatering om den planerade transaktionen med ResoTher Pharma A/S
2026-06-26 20:30:00 Kommuniké från årsstämma i Hunter Capital RTO 1 AB (publ)
2026-05-29 00:01:00 Hunter Capital RTO 1 publicerar delårsrapport januari – mars 2026

Show More

News agencies

2026-08-31 07:21:14 Finwire: Hunter Capital RTO1 reports a small loss as planned - CEO: focus on advancing process with ResoTher Pharma
2026-07-06 11:17:33 Finwire: Hunter Capital: Resother Pharma raises SEK 15 million ahead of listing
2026-05-29 07:09:03 Finwire: Hunter Capital RTO1 reports a smaller loss
2026-03-30 10:56:11 Finwire: Hunter Capital RTO1 enters into a letter of intent for reverse acquisition of Resother Pharma
2026-03-27 14:50:51 Finwire: Hunter Capital RTO1 clarifies insider transaction (update)

Show More

Insider trading

*Powered by Modular Finance

Key Numbers

*Compiled data from Millistream

Upcoming reports

2026-11-27 Interim Report 2026-Q3

Annual reports, prospectus etc.

2026-03-16 Årsredovisning 2025